Galderma Group AG (GDERF)
OTCMKTS · Delayed Price · Currency is USD
201.00
-4.25 (-2.07%)
Jan 5, 2026, 4:00 PM EST
Galderma Group AG Market Cap
Galderma Group AG has a market cap or net worth of $49.4 billion as of January 7, 2026. Its market cap has increased by 103.88% in one year.
Market Cap
49.40B
Enterprise Value
51.79B
Revenue
4.69B
Ranking
n/a
PE Ratio
130.68
Stock Price
$201.00
Market Cap Chart
Since March 22, 2024, Galderma Group AG's market cap has increased from 16.92B to 49.40B, an increase of 191.91%. That is a compound annual growth rate of 81.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 49.40B | 1.48% |
| Dec 30, 2025 | 48.68B | 84.67% |
| Dec 30, 2024 | 26.36B | 55.77% |
| Mar 22, 2024 | 16.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 726.40M |
| Elite Pharmaceuticals | 516.25M |
| Northwest Biotherapeutics | 444.91M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 270.65M |